Webinar series on Genomic Epidemiology

Webinar series on Genomic Epidemiology
The  Infectious  Hazard  Management  unit  of  the  Health  Emergencies  Department is  pleased to present the contents from the Genomic Epidemiology Webinar series. This series was designed to enhance the knowledge of the use of genomic surveillance data in the context of surveillance for national public health reporting. The main objectives of this webinar series are:
  • To  strengthen  the  understanding  of  basic  concepts,  principles,  and  methodologies  of  genomic  sequencing;
  • To   provide   countries   with   frameworks   and   tools   to   conduct   bioinformatic   analysis   with   sequencing data and integrate it with national surveillance;
  • To understand the use of genomic sequencing data for public health response.
The seminar was held in 4 days during the months of September and October, 2021.
Below you can view the presentations and webinar videos for each day.

Session 1 -  Introduction to Genomic Epidemiology

Video Session 1

Concepts and Methods of Genomic Epidemiology - Dr. Pimlapas Leekitcharoenphon, Researcher, Research Group for Genomic Epidemiology National Food Institute (DTU Food), Denmark.

Applications of Bioinformatics in the Real-Time Molecular Surveillance of Viral Pathogens - Dr. Niema Moshiri, Assistant Teaching Professor Computer Science & Engineering University of California, San Diego

Field deployment of sequencing technology -practical considerations and solutions - Dr. Ian Goodfellow, Department of Pathology, Cambridge University, United Kingdom.

Session 2 -  Operationalization and Integration of Genomic Data Into National Surveillance

Video Session 2

Objectives of genomic data in enhancing surveillance activities - Dr. Jairo Mendez, Advisor, Infectious Hazard Management Unit at PAHO/WHO.

Genomic surveillance of antimicrobial resistance ​in Shigella sonnei in Belgium 2013-2019​ - Dr. Natalie Fischer, Scienso, National Public Health Institute, Belgium

Large scale genomic surveillance of SARS-CoV-2 in the UK: challenges and lessons learned - Dr. Cristina Ariani, Wellcome Sanger Institute, England, UK

Session 3 - 


Session 4 -